in the news
ASCO: New data set up Veracyte’s nasal swab lung cancer test for launch later this year
Fierce Biotech
May 19, 2021
May 19, 2021
Hormone Therapy for Prostate Cancer? A Genetic Test Could Help Decide
Cancer Currents Blog, National Cancer Institute
Mar 15, 2021
Mar 15, 2021
Meet 22 women who launched and led startups to an IPO, an accomplishment few female founders have ever reached
Business Insider
Feb 9, 2021
Feb 9, 2021
Peninsula diagnostics company Veracyte acquires Decipher Biosciences
San Francisco Business Times
Feb 4, 2021
Feb 4, 2021
COVID-19 is Driving a Shift in How We Value Diagnostic Tests
Timmerman Report
Aug 6, 2020
Aug 6, 2020
Oncology Beyond COVID-19
The MedTech Strategist
Jun 22, 2020
Jun 22, 2020
Dr. Giulia C. Kennedy, Veracyte’s CSO and CMO, Named One of the “2020 Most Influential Women in Bay Area Business”
San Francisco Business Times
Jun 4, 2020
Jun 4, 2020
Veracyte Aims to Expand Diagnostics Reach with $50M NanoString Deal
Xconomy
Dec 3, 2019
Dec 3, 2019
Genomic Sequencing Classifier May Improve Management of Indeterminate Pulmonary Nodules
Healio
Oct 30, 2019
Oct 30, 2019
Nasal Swab Could Help Gauge Smokers’ Odds for Lung Cancer
U.S. News & World Report
Oct 24, 2019
Oct 24, 2019
Molecular classifier helps spot idiopathic pulmonary fibrosis
Reuters Health News
Apr 10, 2019
Apr 10, 2019
Finding a Way in Genomic Diagnostics: Veracyte's Bonnie Anderson on The Long Run
The Long Run with Luke Timmerman
Jan 29, 2019
Jan 29, 2019
Obtaining Diagnostic Test Reimbursement In The Age Of Evidence
Diagnostics World News
Jan 11, 2019
Jan 11, 2019
Can the nose point the way to early lung cancer detection? This Peninsula company's Big Pharma deal aims to find out
San Francisco Business Times
Jan 3, 2019
Jan 3, 2019
Bonnie Anderson, Veracyte CEO, speaks with Bill Vick of PF Warriors about Envisia Genomic Classifier
PF Warriors
Sep 5, 2018
Sep 5, 2018
Veracyte CEO Says RNA Sequencing Data Will Drive Future Pharma Deals, Products
GenomeWeb
Jul 25, 2018
Jul 25, 2018
Novel Genomic Sequence Classifier Improves Detection of Benign Thyroid Nodules
Healio/Endocrine Today
May 29, 2018
May 29, 2018
Genomic Markers for Cancer
MLO
May 24, 2018
May 24, 2018
Better Specificity with Next-Gen Thyroid Gene Sequence Test
MedPage Today
May 22, 2018
May 22, 2018
Veracyte Launches Early-Access Program for Idiopathic Pulmonary Fibrosis Test
GenomeWeb
May 17, 2018
May 17, 2018
How Might Molecular Testing Advance the Care of Patients with Thyroid Nodules Looking to Avoid Unnecessary Surgery?
EndocrineWeb
Feb 9, 2018
Feb 9, 2018
Veracyte’s CEO Named as one of 2017’s Fiercest Women in Life Sciences
FiercePharma
Dec 4, 2017
Dec 4, 2017
Next Generation Genomic Sequencer Improves Thyroid Cancer Diagnosis
EndocrineWeb
Nov 21, 2017
Nov 21, 2017
Study: Veracyte's genomic lung cancer screening cuts invasive procedures in half
FierceBiotech
Nov 1, 2017
Nov 1, 2017
National Cancer Institute highlights Dr. Avi Spira of BU School of Medicine for groundbreaking work in early lung cancer detection, which led to development of Percepta
National Cancer Institute
Sep 12, 2017
Sep 12, 2017
Bucking the Odds: Veracyte’s Route to Building a Sustainable Genomics Dx Business
The MedTech Strategist
Aug 31, 2017
Aug 31, 2017
Gene Classifier 'Great Rule-Out Test' for Thyroid-Nodule Surgery
Medscape
May 10, 2017
May 10, 2017
Hear Veracyte CEO Bonnie Anderson discuss in a “Business Rockstars” interview how the company’s genomic tests are transforming patient care
Business Rockstars
May 5, 2017
May 5, 2017
Read about new data showing potential for a simple, non-invasive nasal swab test — that builds on the genomic technology behind Veracyte’s Percepta classifier — to help predict lung cancer
Reuters Health
Mar 7, 2017
Mar 7, 2017
Molecular Diagnostics to Enhance Lung Cancer Screening & Diagnosis
Oncology Times
Dec 25, 2016
Dec 25, 2016
Veracyte Sees Clinical Evidence, Medicare Coverage as Major MDx Success Factors
GenomeWeb
Sep 9, 2016
Sep 9, 2016
Tuality’s advanced lung cancer test could lead to the end of biopsies
Portland Business Journal
Jan 25, 2016
Jan 25, 2016
Afirma and Cytologically Benign Thyroid Nodules Show Comparable Clinical Behavior
Endocrine Web
Oct 1, 2015
Oct 1, 2015
Using Gene Expression to Diagnose Lung Cancer More Accurately
National Cancer Institute
Jul 6, 2015
Jul 6, 2015
Veracyte lung cancer test could help avoid some risky biopsies
Reuters
May 17, 2015
May 17, 2015
Bonnie Anderson Named One of the Bay Area’s Most Admired CEOs
San Francisco Business Times
Nov 7, 2014
Nov 7, 2014
Faces of Leadership in Diagnostics: Bonnie Anderson, Veracyte
Mendelspod.com
Nov 3, 2014
Nov 3, 2014
Role of Gene Expression Classification in Assessing Thyroid Nodules
Endocrine Web
Aug 22, 2014
Aug 22, 2014
Bonnie Anderson Named One of the Best Bay Area Life Sciences CEOs
San Francisco Business Times
Jan 2, 2014
Jan 2, 2014
Veracyte – 2013 Fierce 15
Fierce Medical Devices
Oct 15, 2013
Oct 15, 2013
Gene Test Enhances Thyroid Biopsy
MedPage Today
May 4, 2013
May 4, 2013
Women of Influence: Bonnie Anderson, Veracyte
Silicon Valley Business Journal
Apr 11, 2013
Apr 11, 2013
Veracyte Wins Over UnitedHealth With Thyroid Cancer Diagnostic
Xconomy
Mar 8, 2013
Mar 8, 2013
Veracyte: How to Build a Molecular Cytology Company
IN VIVO
Feb 21, 2013
Feb 21, 2013
One-on-One with Veracyte's Bonnie Anderson: Staying focused
San Francisco Business Times
Feb 12, 2013
Feb 12, 2013